Stifel Downgrades Soleno Therapeutics Inc. (SLNO) to Hold

April 7, 2026 2:34 AM

Stifel analyst James Condulis downgraded Soleno Therapeutics Inc. (NASDAQ: SLNO) from Buy to Hold with a price target of $53.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found